Daniel Kaufmann

Daniel Kaufmann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniel Kaufmann sits on this spectrum.

Daniel Kaufmann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel Kaufmann sits on this spectrum.

Best Publications

• PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

  Cheryl L Day;Daniel E Kaufmann;Photini Kiepiela;Julia A Brown

  3248
  Citations

• Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.

  Daniel E Kaufmann;Daniel G Kavanagh;Florencia Pereyra;Florencia Pereyra;John J Zaunders

  676
  Citations

• AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

  Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  664
  Citations

• Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy

  Florencia Pereyra;Marylyn M. Addo;Daniel E. Kaufmann;Yang Liu

  655
  Citations

• Transcriptional analysis of HIV-specific CD8 + T cells shows that PD-1 inhibits T cell function by upregulating BATF

  Michael Quigley;Florencia Pereyra;Björn Nilsson;Filippos Porichis

  600
  Citations

• A Blueprint for HIV Vaccine Discovery

  Dennis R. Burton;Rafi Ahmed;Rafi Ahmed;Dan H. Barouch;Dan H. Barouch;Dan H. Barouch;Salvatore T. Butera

  459
  Citations

• Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells

  Mathias Lichterfeld;Daniel E. Kaufmann;Xu G. Yu;Stanley K. Mui

  445
  Citations

• CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)

  Daniel Kaufmann;Giuseppe Pantaleo;Philippe Sudre;Amalio Telenti

  398
  Citations

• CXCL13 is a plasma biomarker of germinal center activity

  Colin Havenar-Daughton;Madelene Lindqvist;Antje Heit;Jennifer E. Wu

  351
  Citations

• Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution

  Todd M. Allen;Marcus Altfeld;Shaun C. Geer;Elizabeth T. Kalife

  346
  Citations

• IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.

  Mark A. Brockman;Mark A. Brockman;Douglas S. Kwon;Douglas S. Kwon;Douglas S. Kwon;Daniel P. Tighe;David F. Pavlik

  333
  Citations

• Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells

  Samantha Reiss;Amy E. Baxter;Kimberly M. Cirelli;Jennifer M. Dan;Jennifer M. Dan

  326
  Citations

• TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection

  Huabiao Chen;Zaza M Ndhlovu;Zaza M Ndhlovu;Dongfang Liu;Lindsay C Porter

  308
  Citations

• Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity

  Maxime Veillette;Anik Désormeaux;Halima Medjahed;Nour-Elhouda Gharsallah

  298
  Citations

• PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention

  Daniel E. Kaufmann;Bruce D. Walker

  293
  Citations

• A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.

  Sirui Zhou;Guillaume Butler-Laporte;Tomoko Nakanishi;David R. Morrison

  278
  Citations

• Limited durability of viral control following treated acute HIV infection.

  Daniel E Kaufmann;Mathias Lichterfeld;Marcus Altfeld;Marylyn M Addo

  249
  Citations

• The HIV-1 gp120 CD4-Bound Conformation Is Preferentially Targeted by Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Sera from HIV-1-Infected Individuals

  Maxime Veillette;Mathieu Coutu;Jonathan Richard;Laurie-Anne Batraville

  220
  Citations

• Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection

  Marion Pardons;Amy E. Baxter;Marta Massanella;Amélie Pagliuzza

  215
  Citations

• Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy.

  Irfan Ullah;Jérémie Prévost;Mark S. Ladinsky;Helen Stone

  207
  Citations